Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 67 Colorectal Neoplasms 36 Central Nervous System Neoplasms 36 Colonic Neoplasms 34 Rectal Neoplasms 32 Glioblastoma 23 Gliosarcoma 20 Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 18 Stomach Neoplasms 16 Pancreatic Neoplasms 15 Sarcoma 14 Ovarian Neoplasms 13 Head and Neck Neoplasms 13 Prostatic Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 11 Melanoma 11 Astrocytoma 11 Esophageal Neoplasms 10 Carcinoma, Ovarian Epithelial 10 Brain Neoplasms 10 Uterine Cervical Neoplasms 9 Kidney Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma, Intraductal, Noninfiltrating 9 Breast Carcinoma In Situ 9 Breast Neoplasms, Male 8 Adenocarcinoma Of Esophagus 8 Liver Neoplasms 7

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡